Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

90Y Bremsstrahlung Imaging for Absorbed-Dose Assessment in High-Dose Radioimmunotherapy.

Minarik, David LU ; Sjögreen Gleisner, Katarina LU ; Lindén, Ola LU ; Wingårdh, Karin LU ; Tennvall, Jan LU ; Strand, Sven-Erik LU and Ljungberg, Michael LU (2010) In Journal of Nuclear Medicine 51(12). p.1974-1978
Abstract
This feasibility study demonstrates (90)Y quantitative bremsstrahlung imaging of patients undergoing high-dose myeloablative (90)Y-ibritumomab treatment. METHODS: The study includes pretherapy (111)In SPECT/CT and planar whole-body (WB) imaging at 7 d and therapy (90)Y SPECT/CT at 6 d and (90)Y WB imaging at 1 d. Time-activity curves and organ-absorbed doses derived from (90)Y SPECT images were compared with pretherapy (111)In estimates. Organ activities derived from (90)Y WB images at the first day were compared with corresponding pretherapy estimates. RESULTS: Pretherapy (111)In images from 3 patients were similar to the (90)Y images. Differences between absorbed-dose estimates from pretherapy (111)In and (90)Y therapy were within 25%,... (More)
This feasibility study demonstrates (90)Y quantitative bremsstrahlung imaging of patients undergoing high-dose myeloablative (90)Y-ibritumomab treatment. METHODS: The study includes pretherapy (111)In SPECT/CT and planar whole-body (WB) imaging at 7 d and therapy (90)Y SPECT/CT at 6 d and (90)Y WB imaging at 1 d. Time-activity curves and organ-absorbed doses derived from (90)Y SPECT images were compared with pretherapy (111)In estimates. Organ activities derived from (90)Y WB images at the first day were compared with corresponding pretherapy estimates. RESULTS: Pretherapy (111)In images from 3 patients were similar to the (90)Y images. Differences between absorbed-dose estimates from pretherapy (111)In and (90)Y therapy were within 25%, except for the lungs. Corresponding activity differences derived from WB images were within 25%. Differences were ascribed to incomplete compensation methods and real differences in pharmacokinetics between pretherapy and therapy. CONCLUSION: Quantitative bremsstrahlung imaging to estimate organ activities and absorbed doses is feasible. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
quantification, activity, radioimmunotherapy, imaging, yttrium, bremsstrahlung
in
Journal of Nuclear Medicine
volume
51
issue
12
pages
1974 - 1978
publisher
Society of Nuclear Medicine
external identifiers
  • wos:000284530300041
  • pmid:21078799
  • scopus:78651289412
  • pmid:21078799
ISSN
0161-5505
DOI
10.2967/jnumed.110.079897
language
English
LU publication?
yes
id
62ce53a8-6835-4b8a-a816-f7a86d5ed8d7 (old id 1731954)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/21078799?dopt=Abstract
date added to LUP
2016-04-01 14:29:53
date last changed
2022-02-27 02:55:55
@article{62ce53a8-6835-4b8a-a816-f7a86d5ed8d7,
  abstract     = {{This feasibility study demonstrates (90)Y quantitative bremsstrahlung imaging of patients undergoing high-dose myeloablative (90)Y-ibritumomab treatment. METHODS: The study includes pretherapy (111)In SPECT/CT and planar whole-body (WB) imaging at 7 d and therapy (90)Y SPECT/CT at 6 d and (90)Y WB imaging at 1 d. Time-activity curves and organ-absorbed doses derived from (90)Y SPECT images were compared with pretherapy (111)In estimates. Organ activities derived from (90)Y WB images at the first day were compared with corresponding pretherapy estimates. RESULTS: Pretherapy (111)In images from 3 patients were similar to the (90)Y images. Differences between absorbed-dose estimates from pretherapy (111)In and (90)Y therapy were within 25%, except for the lungs. Corresponding activity differences derived from WB images were within 25%. Differences were ascribed to incomplete compensation methods and real differences in pharmacokinetics between pretherapy and therapy. CONCLUSION: Quantitative bremsstrahlung imaging to estimate organ activities and absorbed doses is feasible.}},
  author       = {{Minarik, David and Sjögreen Gleisner, Katarina and Lindén, Ola and Wingårdh, Karin and Tennvall, Jan and Strand, Sven-Erik and Ljungberg, Michael}},
  issn         = {{0161-5505}},
  keywords     = {{quantification; activity; radioimmunotherapy; imaging; yttrium; bremsstrahlung}},
  language     = {{eng}},
  number       = {{12}},
  pages        = {{1974--1978}},
  publisher    = {{Society of Nuclear Medicine}},
  series       = {{Journal of Nuclear Medicine}},
  title        = {{90Y Bremsstrahlung Imaging for Absorbed-Dose Assessment in High-Dose Radioimmunotherapy.}},
  url          = {{http://dx.doi.org/10.2967/jnumed.110.079897}},
  doi          = {{10.2967/jnumed.110.079897}},
  volume       = {{51}},
  year         = {{2010}},
}